Company Celator Pharmaceuticals Inc
Equities
US15089R1023
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2016 | Celator Pharmaceuticals : Jazz Pharma to buy Celator in $1.5 billion deal | RE |
2016 | Celator Pharmaceuticals : Jazz Pharma nears deal to buy Celator for about $1.5 billion - WSJ | RE |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Arthur C. Louie
CTO | Chief Tech/Sci/R&D Officer | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 42,470,256 | 39,489,025 ( 92.98 %) | 0 | 92.98 % |
Company contact information
Celator Pharmaceuticals, Inc.
200 PrincetonSouth Corporate Center Suite 180
08628, Ewing
+
http://www.celatorpharma.comSector
1st Jan change | Capi. | |
---|---|---|
+24.45% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.21% | 25.78B | |
-20.95% | 19.26B | |
+2.95% | 12.14B | |
-2.23% | 12.08B | |
+30.55% | 11.98B |
- Stock Market
- Equities
- Stock
- Company Celator Pharmaceuticals Inc